Trazodone is an antidepressant that was first approved in the United States in 1981 for major depressive disorder, but today it is prescribed far more often for insomnia and sleep problems than for depression itself. It belongs to a class called serotonin antagonist and reuptake inhibitors, and the reason it wears so many hats comes down to the way different doses activate different receptors in the brain. That dose-dependent personality makes trazodone one of the more versatile psychiatric medications in common use, and also one of the most frequently misunderstood.
How Dose Changes What Trazodone Does
Most medications work the same way whether you take a little or a lot; the dose just determines how strong the effect is. Trazodone is different. At low doses, around 25 to 100 mg, it primarily blocks histamine and serotonin receptors involved in wakefulness. That is why a small bedtime dose makes you drowsy. At higher doses, typically 150 to 300 mg or more, trazodone begins to meaningfully block the reuptake of serotonin, which is the mechanism behind its antidepressant effect. Research estimating how much of each receptor trazodone occupies at various doses has confirmed that low doses are enough to block the receptors responsible for the sedative effect, while higher doses are needed for antidepressant action.1PubMed. Evaluating the dose-dependent mechanism of action of trazodone by estimation of occupancies for different brain neurotransmitter targets
This split personality explains why your doctor might prescribe 50 mg for sleep and 300 mg for depression. It also explains why trazodone is frequently added to another antidepressant as a sleep aid, rather than being relied on as the sole antidepressant at a low dose. The sedative effect kicks in quickly, often within 30 to 60 minutes of taking a dose. The antidepressant effect, like most antidepressants, takes weeks of consistent higher-dose use to emerge.
Trazodone as an Antidepressant
Depression is the indication trazodone was originally designed and approved for. Head-to-head comparisons have generally found that its antidepressant effectiveness is comparable to other available antidepressants, including SSRIs and older tricyclics.2PubMed Central. Role of trazodone in treatment of major depressive disorder: an update – Section: Abstract In one randomized, double-blind trial of an extended-release formulation, patients taking trazodone saw their depression scores drop by about 49 percent over eight weeks, compared with 41 percent for placebo, a statistically significant difference that appeared as early as the first week.3PubMed Central. Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study – Section: Abstract
Where trazodone has a particular advantage over SSRIs is in its side-effect profile. SSRIs are well known for causing sexual dysfunction and weight gain, two issues that drive many patients to stop taking their medication. Extended-release trazodone has shown a reduced risk of both compared with other antidepressant classes.4BioMed Central / Springer Nature (Annals of General Psychiatry). Targeting heterogeneous depression with trazodone prolonged release: from neuropharmacology to clinical application That matters in real-world practice because an antidepressant only works if the patient keeps taking it.
Trazodone is also useful for the specific type of depression that comes with severe insomnia. Since poor sleep both feeds depression and results from it, an antidepressant that directly improves sleep architecture can break the cycle in ways that a standard SSRI paired with a separate sleeping pill sometimes does not. For people whose depression is dominated by sleep problems, anxiety, and fatigue rather than anhedonia or concentration issues, trazodone can be a particularly good fit.
Trazodone for Sleep
Despite being approved only for depression, trazodone is one of the most commonly prescribed medications for insomnia in the United States and many other countries. Doctors have been writing off-label sleep prescriptions for decades, and the practice is so widespread that many patients do not realize trazodone is technically an antidepressant at all.
The sleep data is genuinely impressive on several measures. A systematic review and meta-analysis of polysomnographic studies found that trazodone increased total sleep time by roughly 40 minutes compared with controls, cut the time it took to fall asleep by about 19 minutes, reduced nighttime awakenings, and decreased the amount of time spent awake after initially falling asleep.5Scientific Reports. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis – Section: Results Critically, trazodone also increased the duration of deep sleep, the restorative stage that is hardest to recover once it is lost.6PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration Patients consistently report feeling that their sleep quality improved, a finding echoed across multiple studies.7Psychiatria Polska. Treatment of insomnia – effect of trazodone and hypnotics on sleep
So why isn’t it universally recommended as a first-line insomnia treatment? The answer is partly about the strength of the evidence and partly about professional guidelines. A clinical appraisal published in 2023 noted that while field clinicians who regularly prescribe trazodone tend to believe it works well, expert panelists reviewing the published literature felt there was limited evidence supporting its formal use as a first-line insomnia agent.8PubMed Central. Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal The gap between how widely trazodone is prescribed for sleep and how thin the rigorous trial data remains is one of the more awkward mismatches in psychiatric medicine. It works well enough that doctors keep prescribing it, but the randomized controlled trials that would officially cement its place are still somewhat lacking in number and size.
One practical advantage over traditional sleeping pills like benzodiazepines or Z-drugs is that trazodone is not classified as a controlled substance. It carries a much lower risk of physical dependence and is generally considered safer if a patient accidentally takes too much. For people who need a long-term nightly sleep aid, that matters a great deal.
PTSD Nightmares
One of the better-studied off-label uses of trazodone is for nightmares associated with post-traumatic stress disorder. In a survey study of 60 patients with chronic PTSD, about 72 percent found that trazodone reduced their nightmares, with the average number of nightmare nights dropping from about three per week to one.9PubMed. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares – Section: RESULTS PTSD-related nightmares are notoriously difficult to treat, and while prazosin gets more attention in clinical guidelines, trazodone’s dual effect on sleep quality and nightmare frequency makes it a useful alternative when prazosin alone is not enough or is not tolerated.
Agitation in Dementia
Trazodone has also been tried as a treatment for the agitation and behavioral disruptions common in dementia. A small double-blind trial comparing trazodone (50 to 250 mg daily) with haloperidol (a traditional antipsychotic) found the two equally effective for overall agitated behavior, but haloperidol caused more side effects. The study also suggested that specific symptoms responded differently: repetitive and verbally aggressive behaviors improved more with trazodone, while excessive motor activity responded better to haloperidol.10PubMed. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia
However, a Cochrane systematic review concluded that the evidence base is too thin to formally recommend trazodone for this purpose, and called for larger, longer trials.11PubMed. Trazodone for agitation in dementia – Section: REVIEWERS’ CONCLUSIONS In practice, clinicians sometimes reach for trazodone in dementia patients because it avoids the serious risks that come with antipsychotics in elderly populations, including stroke. The evidence is encouraging but far from settled.
Sleep Problems After Alcohol Detoxification
People recovering from alcohol dependence often experience terrible insomnia that can persist for months after they stop drinking, and that insomnia is a significant risk factor for relapse. Trazodone has been studied in this population with mixed results. A double-blind placebo-controlled trial found that trazodone improved sleep quality during the period it was being taken, but once the drug was stopped, sleep quality equalized with placebo.12PubMed Central. Trazodone For Sleep Disturbance After Alcohol Detoxification: A Double-Blind, Placebo-Controlled Trial – Section: Results Another trial confirmed that trazodone improved sleep efficiency and reduced awakenings in patients after alcohol withdrawal.13Journal of Clinical Psychopharmacology. Double-Blind, Placebo-Controlled Study of the Efficacy of Trazodone in Alcohol Post-Withdrawal Syndrome: Polysomnographic and Clinical Evaluations
There is a complication, though. A 2025 paper raised concern that trazodone may actually worsen drinking behavior in some patients with alcohol use disorder, and suggested that clinicians consider safer alternatives when possible.14PubMed Central. Rethinking trazodone for insomnia in alcohol use disorder – Section: MAIN BODY The concern is that the sedative mechanism may lower inhibition or that improving sleep artificially may not address the underlying neurological disruption. If you are in recovery and your doctor suggests trazodone for sleep, the potential benefit is real but should be weighed against this emerging caution.
Side Effects Worth Knowing About
The most common side effect of trazodone is drowsiness, which is also the reason many people are taking it in the first place. At sleep-dose levels, this is the point. At antidepressant doses, it can be a nuisance that some patients manage by taking the full dose at bedtime. Other common side effects include dizziness, dry mouth, and nausea.
There are also some rarer but more serious concerns:
- Priapism: Trazodone is one of the few medications that can cause priapism, a prolonged and painful erection unrelated to sexual arousal. This is uncommon but constitutes a medical emergency requiring immediate treatment. The mechanism relates to trazodone’s ability to block alpha-adrenergic receptors in certain smooth muscle tissue. Men starting trazodone should be aware of this risk, even though most will never experience it.
- Orthostatic hypotension: Blood pressure dropping when you stand up is a well-known effect, and it matters most in elderly patients. A study of geriatric outpatients with hypertension found that trazodone users had a higher incidence of syncope and falls compared with non-users, though when the analysis adjusted for dementia diagnosis, the association weakened.15PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension – Section: Results Falls in elderly patients can be devastating, so this is not a minor concern.
- Heart rhythm effects: At standard doses, trazodone has a modest, dose-dependent effect on the QT interval, a measure of cardiac electrical activity. A study of healthy subjects found no significant QT prolongation at 20 mg, but the effect exceeded regulatory thresholds at 60 mg and 140 mg.16PubMed Central. Effect of 3 Single Doses of Trazodone on QTc Interval in Healthy Subjects The researchers noted this is unlikely to represent a real risk for dangerous heart rhythms at normal doses, but caution is warranted if you are taking other medications that also affect the QT interval. In overdose, the cardiac effects become much more concerning, with case reports documenting serious rhythm disturbances including in young patients with no prior heart disease.17PubMed. QT Prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone
Serotonin Syndrome and Drug Combinations
Because trazodone affects serotonin, combining it with other serotonergic drugs raises the risk of serotonin syndrome, a potentially life-threatening condition marked by agitation, rapid heart rate, high body temperature, muscle twitching, and confusion. A case report described a 25-year-old man who developed serotonin syndrome after rapid dose increases of sertraline, trazodone, and risperidone together.18PubMed. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use
This does not mean trazodone cannot be used alongside an SSRI. In fact, one of the most common clinical scenarios is a patient on an SSRI for depression who adds low-dose trazodone at bedtime for insomnia. The risk is manageable when doses are kept moderate and titrated slowly. An analysis of the FDA’s adverse event database found that the drug combinations most frequently linked to serotonin syndrome reports were SSRI-plus-antidepressant and SSRI-plus-opioid pairings, particularly with tramadol and fentanyl.19Medical Principles and Practice. Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: Analysis of the FDA Adverse Event Reporting System – Section: Results The lesson is less about avoiding combinations entirely and more about being careful with dose changes and watching for early symptoms.
Why Your Other Medications Matter
Trazodone is broken down in the liver primarily by an enzyme called CYP3A4.20Drug Metabolism and Disposition. Trazodone Is Metabolized to m-Chlorophenylpiperazine by CYP3A4 from Human Sources – Section: Discussion That enzyme is involved in metabolizing a huge number of medications, so drugs that inhibit or accelerate CYP3A4 activity can dramatically change how much trazodone ends up in your bloodstream. Strong CYP3A4 inhibitors, like ketoconazole (an antifungal) and certain HIV medications including ritonavir and indinavir, slow the breakdown of trazodone and can effectively increase your dose without you taking more pills.21PubMed. In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors – Section: RESULTS This kind of interaction is especially relevant for the cardiac effects described earlier, since higher trazodone blood levels mean more QT prolongation.
The CYP3A4 pathway also produces trazodone’s main active metabolite, a compound called mCPP. This metabolite acts on serotonin receptors in its own right and can cause effects like anxiety and nausea in some people.22PubMed. Metabolism of m-CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects When CYP3A4 is inhibited, less mCPP is produced, which might sound like a good thing, except it also means more trazodone itself is hanging around. The balance of parent drug and metabolite shifts in ways that can be difficult to predict, which is one reason your pharmacist may flag interactions you didn’t expect.
Pregnancy and Breastfeeding
Data on trazodone during pregnancy and breastfeeding is thin, which is typical for psychiatric medications because pregnant and nursing women are excluded from clinical trials for ethical reasons. One detailed case report measured trazodone and mCPP concentrations in cord blood, breast milk, and neonatal serum. The cord blood concentrations were comparable to maternal levels, meaning the drug does cross the placenta substantially. Concentrations in breast milk were lower. The infant required temporary oxygen support after birth but had no detectable drug-related adverse effects at follow-up through six months.23PubMed Central. Trazodone Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum The authors emphasized that the safety of trazodone for fetuses and breastfed infants cannot be confirmed from a single case, and further studies are needed.
If you are pregnant or planning to become pregnant while taking trazodone, the decision about whether to continue is one to make with your doctor. Untreated depression during pregnancy carries its own serious risks, so the conversation is rarely as simple as “stop the medication.”
Trazodone in Veterinary Medicine
If you have a dog who panics at the veterinarian’s office or trembles through thunderstorms, you may have encountered trazodone in a very different context. Veterinarians commonly prescribe it to manage acute situational fear and anxiety in dogs and cats, typically given an hour or two before a stressful event like a vet visit or travel.24PubMed Central. A review of pre-appointment medications to reduce fear and anxiety in dogs and cats at veterinary visits The sedative mechanism is the same one that helps humans sleep, and the drug has become one of the standard pre-appointment medications in small-animal practice alongside gabapentin. Pet owners sometimes find it surprising that a human antidepressant is their vet’s go-to anxiety medication, but trazodone’s safety margin and lack of controlled-substance status make it a practical choice for animals as well.
How Trazodone Compares to Newer Sleep Medications
The insomnia market has expanded considerably since trazodone first gained its off-label reputation in the 1990s. Newer drugs targeting orexin receptors, like suvorexant and lemborexant, were designed specifically for insomnia and have large, well-controlled trials behind them. Standard Z-drugs like zolpidem remain widely prescribed. So why does trazodone persist?
Cost is part of the answer. Generic trazodone is inexpensive, sometimes drastically so compared with newer branded sleep medications. The lack of controlled-substance classification is another factor, since many newer sleep drugs carry scheduling restrictions that limit refills and require more monitoring. Doctors may also prefer trazodone when a patient has co-occurring depression or anxiety, since a single medication can address both sleep and mood symptoms rather than stacking separate prescriptions.
The trade-off is that trazodone comes with a broader side-effect profile than drugs designed exclusively for sleep. Drowsiness can bleed into the next morning, especially at higher doses or in older patients. The blood-pressure effects and the rare risk of priapism have no equivalent with most newer insomnia drugs. For someone whose only problem is difficulty falling asleep, a purpose-built insomnia medication may be a cleaner choice. For someone dealing with depression, anxiety, and insomnia together, trazodone’s multi-target pharmacology is its strength rather than its limitation.